| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.848 | 0.003 | 0.848 | 5 Hydroxytryptamine release stimulant | 0.785 0.004 CID_193088 0.806 0.004 CID_681 | ||
| 0.696 | 0.003 | 0.696 | Alcohol oxidase inhibitor | 0.076 0.026 CID_193088 0.365 0.004 CID_681 | ||
| 0.646 | 0.002 | 0.691 | Phenylalanine 4-hydroxylase inhibitor | 0.146 0.012 CID_193088 0.691 0.001 CID_681 | CID_681 | |
| 0.654 | 0.012 | 0.662 | Aldehyde oxidase inhibitor | 0.662 0.012 CID_681 | CID_681 | |
| 0.641 | 0.005 | 0.696 | Superoxide dismutase inhibitor | 0.696 0.004 CID_681 | CID_681 | |
| 0.633 | 0.003 | 0.65 | Tyrosine 3 hydroxylase inhibitor | 0.65 0.003 CID_681 | CID_681 | |
| 0.597 | 0.003 | 0.597 | GABA C receptor agonist | 0.191 0.022 CID_193088 0.557 0.003 CID_681 | ||
| 0.597 | 0.004 | 0.611 | Peroxidase inhibitor | 0.611 0.004 CID_681 | CID_681 | |
| 0.553 | 0.002 | 0.634 | Glutamate decarboxylase inhibitor | 0.119 0.021 CID_193088 0.634 0.002 CID_681 | CID_681 | |
| 0.553 | 0.014 | 0.553 | GABA C receptor rho-3 antagonist | 0.471 0.034 CID_681 | ||
| 0.524 | 0.004 | 0.57 | 5 Hydroxytryptamine uptake stimulant | 0.247 0.083 CID_193088 0.57 0.003 CID_681 | CID_681 | |
| 0.541 | 0.021 | 0.609 | 5 Hydroxytryptamine release inhibitor | 0.609 0.01 CID_193088 0.481 0.039 CID_681 | CID_193088 | |
| 0.513 | 0.023 | 0.513 | Calcium channel L-type activator | 0.262 0.193 CID_193088 0.447 0.052 CID_681 | ||
| 0.537 | 0.048 | 0.569 | Caspase 9 stimulant | 0.51 0.056 CID_193088 0.569 0.041 CID_681 | CID_681 | |
| 0.494 | 0.011 | 0.502 | Psychostimulant | 0.502 0.01 CID_193088 0.496 0.011 CID_681 | CID_193088 | |
| 0.468 | 0.003 | 0.473 | Carbonic anhydrase XV inhibitor | 0.106 0.059 CID_193088 0.473 0.003 CID_681 | CID_681 | |
| 0.456 | 0.003 | 0.458 | Histidine decarboxylase inhibitor | 0.086 0.038 CID_193088 0.458 0.003 CID_681 | CID_681 | |
| 0.45 | 0.008 | 0.468 | Phospholipase C inhibitor | 0.36 0.013 CID_193088 0.468 0.007 CID_681 | CID_681 | |
| 0.433 | 0.004 | 0.433 | Porphobilinogen synthase inhibitor | 0.364 0.004 CID_681 | ||
| 0.442 | 0.032 | 0.571 | Spasmolytic | 0.571 0.016 CID_193088 0.476 0.027 CID_681 | CID_193088 | |
| 0.456 | 0.052 | 0.752 | Transcription factor NF kappa B inhibitor | 0.752 0.016 CID_193088 0.492 0.045 CID_681 | CID_193088 | |
| 0.448 | 0.055 | 0.503 | 15-Lipoxygenase inhibitor | 0.503 0.04 CID_681 | CID_681 | |
| 0.393 | 0.004 | 0.433 | Carbonic anhydrase VI inhibitor | 0.19 0.014 CID_193088 0.433 0.004 CID_681 | CID_681 | |
| 0.407 | 0.022 | 0.407 | Calcium channel activator | 0.391 0.028 CID_681 | ||
| 0.439 | 0.055 | 0.533 | Histamine release inhibitor | 0.533 0.019 CID_193088 0.44 0.055 CID_681 | CID_193088 | |
| 0.398 | 0.017 | 0.398 | Anesthetic general | 0.379 0.019 CID_193088 0.384 0.019 CID_681 | ||
| 0.39 | 0.024 | 0.39 | Insulysin inhibitor | 0.386 0.024 CID_681 | ||
| 0.365 | 0.001 | 0.4 | Dopamine D5 agonist | 0.4 0.001 CID_681 | CID_681 | |
| 0.366 | 0.005 | 0.366 | NMDA receptor antagonist | 0.258 0.009 CID_681 | ||
| 0.39 | 0.03 | 0.492 | Interleukin 2 agonist | 0.492 0.009 CID_193088 0.373 0.036 CID_681 | CID_193088 | |
| 0.394 | 0.037 | 0.606 | Vasodilator, coronary | 0.606 0.007 CID_193088 0.425 0.028 CID_681 | CID_193088 | |
| 0.363 | 0.008 | 0.363 | 5 Hydroxytryptamine 1E antagonist | 0.349 0.01 CID_681 | ||
| 0.361 | 0.011 | 0.374 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.295 0.025 CID_193088 0.374 0.01 CID_681 | CID_681 | |
| 0.366 | 0.021 | 0.366 | Growth hormone agonist | 0.13 0.107 CID_193088 0.316 0.029 CID_681 | ||
| 0.348 | 0.003 | 0.348 | GABA aminotransferase inhibitor | 0.277 0.004 CID_193088 0.306 0.003 CID_681 | ||
| 0.376 | 0.033 | 0.592 | Free radical scavenger | 0.592 0.009 CID_193088 0.489 0.017 CID_681 | CID_193088 | |
| 0.346 | 0.005 | 0.358 | Nitric-oxide synthase stimulant | 0.344 0.005 CID_193088 0.358 0.004 CID_681 | CID_681 | |
| 0.382 | 0.053 | 0.655 | Cholesterol antagonist | 0.655 0.012 CID_193088 0.392 0.051 CID_681 | CID_193088 | |
| 0.33 | 0.005 | 0.343 | Carbonic anhydrase III inhibitor | 0.196 0.017 CID_193088 0.343 0.005 CID_681 | CID_681 | |
| 0.325 | 0.004 | 0.325 | GABA C receptor antagonist | 0.255 0.006 CID_681 | ||
| 0.352 | 0.038 | 0.352 | Interleukin antagonist | 0.144 0.123 CID_193088 0.29 0.05 CID_681 | ||
| 0.308 | 0.004 | 0.308 | 5 Hydroxytryptamine 3E antagonist | 0.294 0.005 CID_681 | ||
| 0.334 | 0.034 | 0.491 | Interleukin agonist | 0.491 0.009 CID_193088 0.374 0.023 CID_681 | CID_193088 | |
| 0.302 | 0.003 | 0.322 | Adenylate cyclase stimulant | 0.218 0.008 CID_193088 0.322 0.002 CID_681 | CID_681 | |
| 0.303 | 0.005 | 0.319 | Carbonic anhydrase XIII inhibitor | 0.311 0.005 CID_193088 0.319 0.005 CID_681 | CID_681 | |
| 0.382 | 0.085 | 0.678 | Antibacterial | 0.678 0.01 CID_193088 0.396 0.079 CID_681 | CID_193088 | |
| 0.3 | 0.004 | 0.3 | Creatine kinase inhibitor | 0.268 0.005 CID_681 | ||
| 0.314 | 0.02 | 0.445 | Peptidyltransferase inhibitor | 0.445 0.005 CID_193088 0.319 0.019 CID_681 | CID_193088 | |
| 0.305 | 0.012 | 0.399 | M18 aspartyl aminopeptidase inhibitor | 0.399 0.005 CID_681 | CID_681 | |
| 0.296 | 0.004 | 0.296 | 5 Hydroxytryptamine 1B agonist | 0.189 0.004 CID_681 | ||
| 0.296 | 0.005 | 0.296 | NMDA 2 receptor antagonist | 0.196 0.01 CID_681 | ||
| 0.338 | 0.05 | 0.642 | Antioxidant | 0.642 0.009 CID_193088 0.441 0.028 CID_681 | CID_193088 | |
| 0.299 | 0.014 | 0.319 | Adenylate cyclase inhibitor | 0.195 0.027 CID_193088 0.319 0.012 CID_681 | CID_681 | |
| 0.327 | 0.043 | 0.334 | Transcription factor STAT inhibitor | 0.334 0.04 CID_681 | CID_681 | |
| 0.287 | 0.003 | 0.287 | Histamine N-methyltransferase inhibitor | 0.085 0.061 CID_193088 0.216 0.005 CID_681 | ||
| 0.287 | 0.004 | 0.287 | 5 Hydroxytryptamine 3A agonist | 0.242 0.006 CID_681 | ||
| 0.327 | 0.048 | 0.358 | DNA damaging | 0.358 0.039 CID_193088 0.334 0.046 CID_681 | CID_193088 | |
| 0.289 | 0.013 | 0.289 | Aldehyde dehydrogenase inhibitor | 0.246 0.019 CID_193088 0.204 0.027 CID_681 | ||
| 0.295 | 0.019 | 0.316 | Neurotrophic factor enhancer | 0.301 0.018 CID_193088 0.316 0.014 CID_681 | CID_681 | |
| 0.341 | 0.067 | 0.592 | Immunostimulant | 0.592 0.018 CID_193088 0.331 0.07 CID_681 | CID_193088 | |
| 0.281 | 0.011 | 0.297 | Cystathionine beta-synthase inhibitor | 0.235 0.017 CID_193088 0.297 0.01 CID_681 | CID_681 | |
| 0.31 | 0.043 | 0.436 | Amyloid beta aggregation inhibitor | 0.172 0.093 CID_193088 0.436 0.02 CID_681 | CID_681 | |
| 0.286 | 0.024 | 0.473 | Melanin inhibitor | 0.473 0.008 CID_193088 0.304 0.021 CID_681 | CID_193088 | |
| 0.281 | 0.02 | 0.462 | Protein kinase stimulant | 0.462 0.005 CID_193088 0.294 0.017 CID_681 | CID_193088 | |
| 0.277 | 0.017 | 0.277 | Neurotensin receptor agonist | 0.242 0.022 CID_681 | ||
| 0.327 | 0.073 | 0.748 | Antithrombotic | 0.748 0.006 CID_193088 0.345 0.066 CID_681 | CID_193088 | |
| 0.273 | 0.024 | 0.275 | MAO inhibitor | 0.275 0.023 CID_681 | CID_681 | |
| 0.265 | 0.018 | 0.304 | NADPH oxidase inhibitor | 0.195 0.036 CID_193088 0.304 0.012 CID_681 | CID_681 | |
| 0.249 | 0.004 | 0.249 | GABA C receptor rho-1 antagonist | 0.198 0.008 CID_681 | ||
| 0.312 | 0.068 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.231 0.149 CID_193088 0.294 0.085 CID_681 | ||
| 0.247 | 0.004 | 0.264 | DOPA decarboxylase inhibitor | 0.095 0.087 CID_193088 0.264 0.003 CID_681 | CID_681 | |
| 0.245 | 0.004 | 0.258 | Myeloperoxidase inhibitor | 0.258 0.004 CID_681 | CID_681 | |
| 0.261 | 0.021 | 0.454 | Alpha-N-acetylglucosaminidase inhibitor | 0.454 0.007 CID_193088 0.23 0.026 CID_681 | CID_193088 | |
| 0.242 | 0.004 | 0.242 | NMDA 2A receptor antagonist | 0.155 0.007 CID_681 | ||
| 0.309 | 0.075 | 0.354 | 12-Lipoxygenase inhibitor | 0.354 0.055 CID_681 | CID_681 | |
| 0.237 | 0.005 | 0.237 | Prolactin inhibitor | 0.235 0.005 CID_681 | ||
| 0.255 | 0.024 | 0.255 | Acetylcholine M1 receptor antagonist | 0.238 0.028 CID_681 | ||
| 0.255 | 0.023 | 0.524 | Monophenol monooxygenase inhibitor | 0.524 0.007 CID_193088 0.277 0.021 CID_681 | CID_193088 | |
| 0.244 | 0.014 | 0.244 | Ferrochelatase inhibitor | 0.213 0.02 CID_681 | ||
| 0.233 | 0.005 | 0.235 | Adrenaline agonist | 0.235 0.005 CID_681 | CID_681 | |
| 0.242 | 0.014 | 0.242 | Aminopeptidase B inhibitor | 0.087 0.075 CID_193088 0.214 0.018 CID_681 | ||
| 0.25 | 0.022 | 0.273 | Succinate dehydrogenase inhibitor | 0.138 0.137 CID_193088 0.273 0.016 CID_681 | CID_681 | |
| 0.281 | 0.055 | 0.415 | Vasodilator | 0.415 0.021 CID_193088 0.326 0.04 CID_681 | CID_193088 | |
| 0.231 | 0.004 | 0.239 | Carbonic anhydrase VB inhibitor | 0.239 0.004 CID_681 | CID_681 | |
| 0.267 | 0.041 | 0.267 | Neuropeptide Y2 antagonist | 0.233 0.073 CID_681 | ||
| 0.229 | 0.005 | 0.229 | CYP2A6 inhibitor | 0.196 0.008 CID_681 | ||
| 0.28 | 0.057 | 0.784 | Angiogenesis stimulant | 0.784 0.004 CID_193088 0.297 0.05 CID_681 | CID_193088 | |
| 0.254 | 0.032 | 0.268 | Insulin sensitizer | 0.25 0.034 CID_193088 0.268 0.025 CID_681 | CID_681 | |
| 0.232 | 0.013 | 0.249 | Toll-Like receptor 2 antagonist | 0.103 0.1 CID_193088 0.249 0.009 CID_681 | CID_681 | |
| 0.229 | 0.012 | 0.229 | 5 Hydroxytryptamine agonist | 0.184 0.016 CID_681 | ||
| 0.276 | 0.062 | 0.693 | Hypoglycemic | 0.693 0.005 CID_193088 0.301 0.052 CID_681 | CID_193088 | |
| 0.269 | 0.056 | 0.428 | DNA synthesis inhibitor | 0.428 0.019 CID_193088 0.228 0.084 CID_681 | CID_193088 | |
| 0.278 | 0.065 | 0.299 | Transcription factor STAT3 inhibitor | 0.299 0.054 CID_681 | CID_681 | |
| 0.217 | 0.005 | 0.217 | NMDA 2C receptor antagonist | 0.127 0.009 CID_681 | ||
| 0.213 | 0.004 | 0.213 | 5 Hydroxytryptamine 2A agonist | 0.174 0.004 CID_681 | ||
| 0.213 | 0.006 | 0.223 | Carbonic anhydrase V inhibitor | 0.223 0.005 CID_681 | CID_681 | |
| 0.24 | 0.034 | 0.24 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.236 0.035 CID_681 | ||
| 0.212 | 0.008 | 0.227 | Nitric-oxide synthase inhibitor | 0.227 0.006 CID_681 | CID_681 | |
| 0.209 | 0.007 | 0.225 | Inducible nitric-oxide synthase inhibitor | 0.225 0.006 CID_681 | CID_681 | |
| 0.291 | 0.092 | 0.508 | Apoptosis antagonist | 0.508 0.019 CID_193088 0.329 0.067 CID_681 | CID_193088 | |
| 0.229 | 0.03 | 0.229 | Phospholipase A2 inhibitor | 0.202 0.041 CID_193088 0.227 0.031 CID_681 | ||
| 0.232 | 0.033 | 0.52 | Amylase inhibitor | 0.52 0.005 CID_193088 0.247 0.029 CID_681 | CID_193088 | |
| 0.212 | 0.015 | 0.575 | Cyclooxygenase 3 inhibitor | 0.575 0.003 CID_193088 0.214 0.014 CID_681 | CID_193088 | |
| 0.207 | 0.01 | 0.251 | HIV-1 integrase (Overall Integration) inhibitor | 0.251 0.005 CID_681 | CID_681 | |
| 0.203 | 0.007 | 0.203 | Transcription factor STAT6 inhibitor | 0.18 0.01 CID_681 | ||
| 0.22 | 0.026 | 0.561 | Hemostatic | 0.561 0.004 CID_193088 0.25 0.022 CID_681 | CID_193088 | |
| 0.215 | 0.022 | 0.215 | MAO B inhibitor | 0.214 0.022 CID_681 | ||
| 0.347 | 0.154 | 0.347 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.319 0.188 CID_681 | ||
| 0.214 | 0.022 | 0.214 | GABA C receptor rho-2 antagonist | 0.172 0.049 CID_681 | ||
| 0.209 | 0.017 | 0.209 | CF transmembrane conductance regulator agonist | 0.154 0.069 CID_193088 0.183 0.034 CID_681 | ||
| 0.213 | 0.022 | 0.28 | Chelator | 0.28 0.013 CID_681 | CID_681 | |
| 0.273 | 0.085 | 0.322 | Lipoxygenase inhibitor | 0.322 0.061 CID_681 | CID_681 | |
| 0.24 | 0.054 | 0.359 | DNA methylase inhibitor | 0.359 0.015 CID_193088 0.266 0.04 CID_681 | CID_193088 | |
| 0.191 | 0.005 | 0.191 | Lanosterol 14 alpha demethylase inhibitor | 0.157 0.009 CID_681 | ||
| 0.19 | 0.004 | 0.216 | GABA B receptor agonist | 0.216 0.003 CID_681 | CID_681 | |
| 0.244 | 0.058 | 0.244 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.237 0.061 CID_681 | ||
| 0.197 | 0.013 | 0.228 | Vanilloid 1 agonist | 0.179 0.019 CID_193088 0.228 0.007 CID_681 | CID_681 | |
| 0.187 | 0.003 | 0.187 | Estrogen-related receptor beta agonist | 0.166 0.003 CID_681 | ||
| 0.21 | 0.026 | 0.404 | Cell wall synthesis inhibitor | 0.404 0.006 CID_193088 0.204 0.028 CID_681 | CID_193088 | |
| 0.185 | 0.006 | 0.192 | Carbonic anhydrase VA inhibitor | 0.192 0.005 CID_681 | CID_681 | |
| 0.193 | 0.014 | 0.193 | Estrogen antagonist | 0.133 0.035 CID_681 | ||
| 0.191 | 0.013 | 0.191 | TRPA1 agonist | 0.124 0.054 CID_193088 0.187 0.014 CID_681 | ||
| 0.237 | 0.059 | 0.244 | RNA-directed DNA polymerase inhibitor | 0.201 0.098 CID_193088 0.244 0.053 CID_681 | CID_681 | |
| 0.19 | 0.013 | 0.19 | Alcohol dehydrogenase inhibitor | 0.138 0.025 CID_193088 0.147 0.021 CID_681 | ||
| 0.192 | 0.015 | 0.192 | Opioid antagonist | 0.138 0.03 CID_681 | ||
| 0.184 | 0.01 | 0.191 | Heat shock protein 70 antagonist | 0.191 0.008 CID_193088 0.186 0.009 CID_681 | CID_193088 | |
| 0.173 | 0.002 | 0.173 | Dopamine beta hydroxylase inhibitor | 0.168 0.003 CID_681 | ||
| 0.179 | 0.012 | 0.179 | 5 Hydroxytryptamine 1 agonist | 0.128 0.016 CID_681 | ||
| 0.241 | 0.074 | 0.241 | Calpain inhibitor | 0.236 0.079 CID_681 | ||
| 0.199 | 0.035 | 0.227 | Death-associated protein kinase 2 inhibitor | 0.227 0.02 CID_681 | CID_681 | |
| 0.175 | 0.01 | 0.181 | Macrophage migration inhibitory factor inhibitor | 0.181 0.01 CID_681 | CID_681 | |
| 0.248 | 0.084 | 0.277 | Cardiotonic | 0.277 0.066 CID_681 | CID_681 | |
| 0.179 | 0.015 | 0.189 | Sphingosine 1-phosphate receptor 2 antagonist | 0.189 0.011 CID_681 | CID_681 | |
| 0.174 | 0.011 | 0.175 | Keratolytic | 0.175 0.011 CID_681 | CID_681 | |
| 0.239 | 0.076 | 0.333 | Antiamyloidogenic | 0.333 0.043 CID_193088 0.299 0.052 CID_681 | CID_193088 | |
| 0.273 | 0.111 | 0.32 | Vasodilator, peripheral | 0.253 0.125 CID_193088 0.32 0.087 CID_681 | CID_681 | |
| 0.174 | 0.012 | 0.174 | Glutamate dehydrogenase inhibitor | 0.122 0.022 CID_193088 0.155 0.015 CID_681 | ||
| 0.179 | 0.018 | 0.265 | Photosensitizer | 0.265 0.005 CID_193088 0.154 0.029 CID_681 | CID_193088 | |
| 0.176 | 0.015 | 0.176 | Opioid delta receptor antagonist | 0.123 0.025 CID_681 | ||
| 0.193 | 0.033 | 0.201 | Histone deacetylase SIRT1 inhibitor | 0.201 0.03 CID_681 | CID_681 | |
| 0.175 | 0.016 | 0.186 | Sphingomyelinase inhibitor | 0.163 0.02 CID_193088 0.186 0.013 CID_681 | CID_681 | |
| 0.178 | 0.02 | 0.264 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.264 0.008 CID_193088 0.154 0.025 CID_681 | CID_193088 | |
| 0.194 | 0.036 | 0.194 | Nav1.2 sodium channel blocker | 0.156 0.054 CID_681 | ||
| 0.167 | 0.01 | 0.167 | Aminopeptidase I inhibitor | 0.141 0.014 CID_681 | ||
| 0.18 | 0.024 | 0.188 | Sphingosine 1-phosphate receptor 5 antagonist | 0.188 0.018 CID_681 | CID_681 | |
| 0.175 | 0.02 | 0.186 | Mucolytic | 0.186 0.017 CID_193088 0.185 0.017 CID_681 | CID_193088 | |
| 0.193 | 0.039 | 0.198 | Arachidonic acid antagonist | 0.198 0.035 CID_681 | CID_681 | |
| 0.162 | 0.008 | 0.169 | Ornithine decarboxylase inhibitor | 0.135 0.017 CID_193088 0.169 0.007 CID_681 | CID_681 | |
| 0.165 | 0.013 | 0.165 | Estrogen receptor beta antagonist | 0.119 0.033 CID_681 | ||
| 0.172 | 0.02 | 0.172 | Adenylate kinase inhibitor | 0.139 0.031 CID_193088 0.154 0.025 CID_681 | ||
| 0.166 | 0.014 | 0.166 | Opioid mu receptor antagonist | 0.113 0.027 CID_681 | ||
| 0.154 | 0.005 | 0.154 | Kinesin-like protein 1 inhibitor | 0.112 0.006 CID_681 | ||
| 0.154 | 0.005 | 0.154 | Kinesin antagonist | 0.112 0.006 CID_681 | ||
| 0.172 | 0.023 | 0.383 | UDP-glucose 4-epimerase inhibitor | 0.383 0.006 CID_193088 0.152 0.028 CID_681 | CID_193088 | |
| 0.16 | 0.011 | 0.16 | Somatostatin 1 agonist | 0.073 0.06 CID_193088 0.133 0.019 CID_681 | ||
| 0.178 | 0.03 | 0.178 | Cathepsin H inhibitor | 0.151 0.045 CID_681 | ||
| 0.159 | 0.018 | 0.339 | Triose-phosphate isomerase inhibitor | 0.339 0.004 CID_193088 0.142 0.023 CID_681 | CID_193088 | |
| 0.196 | 0.055 | 0.217 | Tumour necrosis factor antagonist | 0.217 0.044 CID_681 | CID_681 | |
| 0.166 | 0.025 | 0.17 | Interleukin 8 antagonist | 0.17 0.023 CID_681 | CID_681 | |
| 0.156 | 0.016 | 0.156 | Opioid kappa receptor antagonist | 0.101 0.034 CID_681 | ||
| 0.156 | 0.016 | 0.307 | NADH dehydrogenase inhibitor | 0.307 0.006 CID_193088 0.142 0.02 CID_681 | CID_193088 | |
| 0.177 | 0.036 | 0.216 | DNA polymerase I inhibitor | 0.187 0.033 CID_193088 0.216 0.024 CID_681 | CID_681 | |
| 0.146 | 0.008 | 0.146 | NMDA receptor agonist | 0.128 0.011 CID_681 | ||
| 0.185 | 0.047 | 0.185 | Catenin beta inhibitor | 0.147 0.113 CID_681 | ||
| 0.167 | 0.029 | 0.167 | Falcipain 3 inhibitor | 0.166 0.029 CID_681 | ||
| 0.171 | 0.034 | 0.171 | Acetylcholine muscarinic antagonist | 0.156 0.04 CID_681 | ||
| 0.271 | 0.134 | 0.526 | Immunosuppressant | 0.526 0.026 CID_193088 0.269 0.135 CID_681 | CID_193088 | |
| 0.243 | 0.107 | 0.269 | Hypoxia-inducible factor 1 alpha inhibitor | 0.269 0.084 CID_193088 0.26 0.092 CID_681 | CID_193088 | |
| 0.153 | 0.018 | 0.153 | Aminoacyl-tRNA synthetase inhibitor | 0.104 0.041 CID_193088 0.135 0.024 CID_681 | ||
| 0.159 | 0.025 | 0.159 | Ca2+-transporting ATPase inhibitor | 0.154 0.033 CID_193088 0.155 0.033 CID_681 | ||
| 0.171 | 0.038 | 0.171 | Neuropeptide Y1 antagonist | 0.147 0.069 CID_681 | ||
| 0.15 | 0.018 | 0.268 | Phosphofructokinase-1 inhibitor | 0.268 0.007 CID_193088 0.134 0.021 CID_681 | CID_193088 | |
| 0.137 | 0.007 | 0.145 | Beta adrenoreceptor antagonist | 0.145 0.006 CID_681 | CID_681 | |
| 0.138 | 0.009 | 0.138 | 5 Hydroxytryptamine 5A antagonist | 0.122 0.011 CID_681 | ||
| 0.159 | 0.03 | 0.159 | Nav1.4 sodium channel blocker | 0.13 0.044 CID_681 | ||
| 0.135 | 0.007 | 0.135 | NMDA receptor subunit 3B antagonist | 0.068 0.016 CID_681 | ||
| 0.13 | 0.004 | 0.13 | Diamine oxidase inhibitor | 0.127 0.004 CID_681 | ||
| 0.154 | 0.029 | 0.156 | Protein kinase C gamma inhibitor | 0.156 0.028 CID_681 | CID_681 | |
| 0.154 | 0.03 | 0.165 | Bronchodilator | 0.165 0.027 CID_681 | CID_681 | |
| 0.163 | 0.039 | 0.175 | Interleukin 4 antagonist | 0.149 0.05 CID_193088 0.175 0.032 CID_681 | CID_681 | |
| 0.176 | 0.053 | 0.329 | Interferon gamma antagonist | 0.329 0.016 CID_193088 0.177 0.052 CID_681 | CID_193088 | |
| 0.139 | 0.016 | 0.213 | Dopamine agonist | 0.213 0.009 CID_681 | CID_681 | |
| 0.132 | 0.01 | 0.132 | Glycine receptor agonist | 0.115 0.014 CID_193088 0.126 0.011 CID_681 | ||
| 0.132 | 0.01 | 0.132 | 5 Hydroxytryptamine 5 antagonist | 0.115 0.012 CID_681 | ||
| 0.126 | 0.004 | 0.126 | MAP kinase kinase 7 inhibitor | 0.109 0.007 CID_681 | ||
| 0.154 | 0.034 | 0.453 | Expectorant | 0.453 0.004 CID_193088 0.173 0.027 CID_681 | CID_193088 | |
| 0.143 | 0.022 | 0.143 | Anabolic | 0.133 0.029 CID_681 | ||
| 0.173 | 0.052 | 0.173 | Thiol protease inhibitor | 0.17 0.054 CID_681 | ||
| 0.181 | 0.061 | 0.382 | Thrombolytic | 0.382 0.013 CID_193088 0.204 0.05 CID_681 | CID_193088 | |
| 0.128 | 0.008 | 0.132 | Beta 3 adrenoreceptor antagonist | 0.132 0.008 CID_681 | CID_681 | |
| 0.125 | 0.006 | 0.245 | Carbonic anhydrase XIV inhibitor | 0.245 0.004 CID_193088 0.133 0.005 CID_681 | CID_193088 | |
| 0.173 | 0.055 | 0.324 | Hexokinase inhibitor | 0.324 0.009 CID_193088 0.158 0.07 CID_681 | CID_193088 | |
| 0.125 | 0.007 | 0.135 | Beta 1 adrenoreceptor antagonist | 0.135 0.006 CID_681 | CID_681 | |
| 0.174 | 0.058 | 0.374 | Diuretic | 0.374 0.014 CID_193088 0.174 0.058 CID_681 | CID_193088 | |
| 0.171 | 0.055 | 0.308 | Lipid peroxidase inhibitor | 0.308 0.018 CID_193088 0.227 0.032 CID_681 | CID_193088 | |
| 0.126 | 0.01 | 0.126 | Glycine transporter 2 inhibitor | 0.089 0.015 CID_681 | ||
| 0.193 | 0.077 | 0.422 | Non-steroidal antiinflammatory agent | 0.422 0.011 CID_193088 0.201 0.07 CID_681 | CID_193088 | |
| 0.162 | 0.046 | 0.162 | Cholinergic antagonist | 0.148 0.053 CID_681 | ||
| 0.155 | 0.042 | 0.163 | Cholesterol synthesis inhibitor | 0.113 0.072 CID_193088 0.163 0.039 CID_681 | CID_681 | |
| 0.159 | 0.046 | 0.159 | Acetylcholine antagonist | 0.145 0.053 CID_681 | ||
| 0.118 | 0.005 | 0.129 | Sphingosine kinase 2 inhibitor | 0.129 0.004 CID_681 | CID_681 | |
| 0.147 | 0.036 | 0.147 | Sphingosine 1-phosphate receptor 4 antagonist | 0.135 0.049 CID_681 | ||
| 0.118 | 0.009 | 0.118 | 5 Hydroxytryptamine 3 agonist | 0.093 0.019 CID_681 | ||
| 0.121 | 0.013 | 0.121 | D-Ala-D-Ala ligase inhibitor | 0.116 0.016 CID_681 | ||
| 0.122 | 0.014 | 0.137 | Carbonic anhydrase stimulant | 0.137 0.012 CID_681 | CID_681 | |
| 0.137 | 0.029 | 0.185 | Toll-Like receptor 4 antagonist | 0.185 0.009 CID_193088 0.13 0.035 CID_681 | CID_193088 | |
| 0.138 | 0.03 | 0.144 | Urease inhibitor | 0.144 0.026 CID_681 | CID_681 | |
| 0.223 | 0.115 | 0.223 | Gastrin inhibitor | 0.208 0.137 CID_681 | ||
| 0.154 | 0.048 | 0.154 | Glutamate receptor antagonist | |||
| 0.15 | 0.044 | 0.15 | Histone deacetylase class III inhibitor | 0.15 0.043 CID_681 | ||
| 0.12 | 0.014 | 0.12 | Acetylcholine M3 receptor antagonist | 0.094 0.02 CID_681 | ||
| 0.11 | 0.005 | 0.11 | Epithelial sodium channel blocker | 0.063 0.024 CID_193088 0.099 0.007 CID_681 | ||
| 0.108 | 0.004 | 0.112 | Beta 2 adrenoreceptor agonist | 0.112 0.004 CID_681 | CID_681 | |
| 0.146 | 0.042 | 0.146 | MAO A inhibitor | 0.143 0.043 CID_681 | ||
| 0.174 | 0.07 | 0.174 | Antipruritic | 0.154 0.09 CID_681 | ||
| 0.122 | 0.02 | 0.128 | Histamine H2 receptor antagonist | 0.128 0.017 CID_681 | CID_681 | |
| 0.143 | 0.042 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.061 CID_681 | ||
| 0.116 | 0.015 | 0.116 | Biliverdin reductase inhibitor | 0.079 0.027 CID_193088 0.1 0.019 CID_681 | ||
| 0.162 | 0.063 | 0.162 | Heat shock protein 90 antagonist | 0.147 0.077 CID_681 | ||
| 0.11 | 0.013 | 0.11 | CC chemokine 5 receptor agonist | 0.091 0.035 CID_681 | ||
| 0.119 | 0.022 | 0.129 | Alpha adrenoreceptor agonist | 0.129 0.02 CID_681 | CID_681 | |
| 0.104 | 0.007 | 0.112 | Beta 2 adrenoreceptor antagonist | 0.112 0.007 CID_681 | CID_681 | |
| 0.101 | 0.004 | 0.101 | Adenylate cyclase 1 inhibitor | 0.096 0.005 CID_681 | ||
| 0.106 | 0.01 | 0.106 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.1 0.014 CID_681 | ||
| 0.141 | 0.045 | 0.266 | Topoisomerase I inhibitor | 0.266 0.014 CID_193088 0.134 0.048 CID_681 | CID_193088 | |
| 0.118 | 0.023 | 0.118 | Analgesic, opioid | 0.082 0.045 CID_681 | ||
| 0.11 | 0.017 | 0.11 | Argininosuccinate synthase inhibitor | 0.076 0.027 CID_193088 0.094 0.021 CID_681 | ||
| 0.113 | 0.019 | 0.113 | Sphingosine 1-phosphate receptor 4 agonist | 0.089 0.031 CID_681 | ||
| 0.121 | 0.029 | 0.121 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.117 0.03 CID_681 | ||
| 0.151 | 0.058 | 0.181 | Neurotrophic factor | 0.13 0.08 CID_193088 0.181 0.037 CID_681 | CID_681 | |
| 0.116 | 0.024 | 0.126 | Glutamate release inhibitor | 0.126 0.019 CID_193088 0.102 0.04 CID_681 | CID_193088 | |
| 0.143 | 0.051 | 0.279 | Alkylator | 0.279 0.014 CID_193088 0.134 0.056 CID_681 | CID_193088 | |
| 0.113 | 0.021 | 0.132 | Na+ K+ transporting ATPase inhibitor | 0.132 0.011 CID_193088 0.111 0.022 CID_681 | CID_193088 | |
| 0.11 | 0.018 | 0.11 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 CID_193088 0.098 0.021 CID_681 | ||
| 0.106 | 0.015 | 0.106 | Purinergic P2X1 antagonist | 0.1 0.017 CID_681 | ||
| 0.113 | 0.022 | 0.183 | Vanilloid agonist | 0.183 0.008 CID_681 | CID_681 | |
| 0.099 | 0.008 | 0.109 | Sphingosine kinase inhibitor | 0.109 0.006 CID_681 | CID_681 | |
| 0.175 | 0.084 | 0.482 | Hepatoprotectant | 0.482 0.008 CID_193088 0.198 0.066 CID_681 | CID_193088 | |
| 0.112 | 0.022 | 0.119 | Granulocyte macrophage colony stimulating factor agonist | 0.119 0.016 CID_681 | CID_681 | |
| 0.099 | 0.009 | 0.099 | 5 Hydroxytryptamine 2 agonist | 0.087 0.013 CID_681 | ||
| 0.104 | 0.015 | 0.111 | Maillard reaction inhibitor | 0.053 0.04 CID_193088 0.111 0.013 CID_681 | CID_681 | |
| 0.146 | 0.058 | 0.165 | Toll-Like receptor antagonist | 0.165 0.046 CID_681 | CID_681 | |
| 0.126 | 0.039 | 0.135 | Acetylcholine release stimulant | 0.135 0.029 CID_193088 0.122 0.046 CID_681 | CID_193088 | |
| 0.109 | 0.022 | 0.109 | Estrogen receptor alpha antagonist | 0.103 0.025 CID_681 | ||
| 0.095 | 0.008 | 0.095 | 5 Hydroxytryptamine 7 agonist | 0.081 0.012 CID_681 | ||
| 0.109 | 0.023 | 0.109 | CXC chemokine 4 receptor antagonist | 0.07 0.036 CID_681 | ||
| 0.171 | 0.085 | 0.284 | DNA methyltransferase I inhibitor | 0.284 0.032 CID_193088 0.207 0.066 CID_681 | CID_193088 | |
| 0.095 | 0.009 | 0.095 | NMDA receptor subunit 3A antagonist | 0.052 0.019 CID_681 | ||
| 0.14 | 0.054 | 0.153 | Anesthetic local | 0.153 0.048 CID_681 | CID_681 | |
| 0.134 | 0.048 | 0.137 | Alpha 2b adrenoreceptor antagonist | 0.137 0.045 CID_681 | CID_681 | |
| 0.162 | 0.078 | 0.162 | Sigma receptor agonist | |||
| 0.098 | 0.017 | 0.098 | Acyl-CoA dehydrogenase inhibitor | 0.052 0.041 CID_193088 0.085 0.02 CID_681 | ||
| 0.19 | 0.109 | 0.397 | Platelet antagonist | 0.397 0.028 CID_193088 0.19 0.109 CID_681 | CID_193088 | |
| 0.102 | 0.021 | 0.102 | Sirtuin 1 inhibitor | 0.096 0.025 CID_681 | ||
| 0.11 | 0.031 | 0.111 | Bile acid receptor antagonist | 0.111 0.03 CID_681 | CID_681 | |
| 0.114 | 0.036 | 0.114 | Protein kinase C zeta inhibitor | 0.11 0.04 CID_681 | ||
| 0.083 | 0.005 | 0.083 | Immunoglobulin Fc receptor antagonist | 0.071 0.01 CID_681 | ||
| 0.157 | 0.08 | 0.157 | Heat shock protein 90 alpha antagonist | 0.146 0.091 CID_681 | ||
| 0.09 | 0.013 | 0.09 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 CID_681 | ||
| 0.085 | 0.008 | 0.09 | Phosphoglycerate kinase inhibitor | 0.039 0.021 CID_193088 0.09 0.008 CID_681 | CID_681 | |
| 0.089 | 0.012 | 0.112 | Dopamine D2 agonist | 0.112 0.009 CID_681 | CID_681 | |
| 0.093 | 0.018 | 0.093 | Ornithine carbamoyltransferase inhibitor | 0.062 0.03 CID_193088 0.083 0.021 CID_681 | ||
| 0.081 | 0.005 | 0.131 | Arginase inhibitor | 0.131 0.003 CID_193088 0.077 0.006 CID_681 | CID_193088 | |
| 0.082 | 0.008 | 0.082 | Leukotriene A4 hydrolase inhibitor | 0.071 0.011 CID_681 | ||
| 0.085 | 0.012 | 0.089 | Carbonic anhydrase VII inhibitor | 0.043 0.036 CID_193088 0.089 0.011 CID_681 | CID_681 | |
| 0.078 | 0.005 | 0.079 | Beta adrenoreceptor agonist | 0.079 0.004 CID_681 | CID_681 | |
| 0.091 | 0.018 | 0.096 | Alpha 2 adrenoreceptor agonist | 0.096 0.016 CID_681 | CID_681 | |
| 0.091 | 0.017 | 0.091 | Glutamate (mGluR7) antagonist | 0.075 0.034 CID_681 | ||
| 0.082 | 0.008 | 0.28 | Mannosidase inhibitor | 0.28 0.002 CID_193088 0.071 0.011 CID_681 | CID_193088 | |
| 0.134 | 0.062 | 0.143 | Antibacterial (Helicobacter pylori) | 0.143 0.053 CID_681 | CID_681 | |
| 0.116 | 0.044 | 0.116 | Potassium channel (Ca-activated) activator | 0.091 0.064 CID_681 | ||
| 0.09 | 0.019 | 0.09 | Urokinase inhibitor | 0.078 0.022 CID_681 | ||
| 0.086 | 0.015 | 0.086 | Histone deacetylase SIRT3 inhibitor | 0.082 0.017 CID_681 | ||
| 0.233 | 0.162 | 0.233 | Calpain 2 inhibitor | |||
| 0.083 | 0.013 | 0.083 | Aconitate hydratase inhibitor | 0.074 0.016 CID_681 | ||
| 0.077 | 0.007 | 0.077 | Dihydropteroate synthase inhibitor | 0.057 0.013 CID_681 | ||
| 0.11 | 0.041 | 0.126 | Alpha 2 adrenoreceptor antagonist | 0.126 0.035 CID_681 | CID_681 | |
| 0.158 | 0.089 | 0.421 | Nitric oxide antagonist | 0.421 0.023 CID_193088 0.198 0.068 CID_681 | CID_193088 | |
| 0.08 | 0.011 | 0.242 | Alpha-mannosidase inhibitor | 0.242 0.003 CID_193088 0.072 0.015 CID_681 | CID_193088 | |
| 0.073 | 0.004 | 0.073 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 CID_681 | ||
| 0.138 | 0.069 | 0.138 | Nav1.6 sodium channel blocker | 0.132 0.077 CID_681 | ||
| 0.101 | 0.033 | 0.101 | Cathepsin G inhibitor | 0.085 0.04 CID_681 | ||
| 0.076 | 0.008 | 0.076 | Histamine H2 receptor agonist | 0.073 0.009 CID_681 | ||
| 0.118 | 0.051 | 0.12 | Alpha 2c adrenoreceptor antagonist | 0.12 0.05 CID_681 | CID_681 | |
| 0.073 | 0.005 | 0.073 | 5 Hydroxytryptamine 2B agonist | 0.061 0.008 CID_681 | ||
| 0.124 | 0.057 | 0.124 | 5 Hydroxytryptamine 2B antagonist | 0.121 0.059 CID_681 | ||
| 0.085 | 0.019 | 0.085 | Glutamate (mGluR6) antagonist | 0.079 0.025 CID_681 | ||
| 0.179 | 0.112 | 0.322 | Cyclic AMP phosphodiesterase inhibitor | 0.322 0.034 CID_193088 0.199 0.095 CID_681 | CID_193088 | |
| 0.148 | 0.082 | 0.332 | Anticoagulant | 0.332 0.024 CID_193088 0.155 0.076 CID_681 | CID_193088 | |
| 0.111 | 0.045 | 0.111 | Electrolyte absorption antagonist | 0.098 0.06 CID_681 | ||
| 0.152 | 0.086 | 0.249 | Interleukin 6 antagonist | 0.249 0.023 CID_193088 0.155 0.082 CID_681 | CID_193088 | |
| 0.084 | 0.018 | 0.084 | Heat shock protein 90 beta antagonist | 0.084 0.018 CID_681 | ||
| 0.136 | 0.071 | 0.136 | Bone formation stimulant | 0.113 0.092 CID_193088 0.111 0.094 CID_681 | ||
| 0.174 | 0.108 | 0.199 | Histone acetyltransferase inhibitor | 0.199 0.07 CID_681 | CID_681 | |
| 0.071 | 0.007 | 0.071 | Geranyltranstransferase inhibitor | 0.067 0.009 CID_681 | ||
| 0.075 | 0.011 | 0.106 | Vanilloid 2 antagonist | 0.106 0.005 CID_681 | CID_681 | |
| 0.099 | 0.037 | 0.114 | Alpha 2a adrenoreceptor antagonist | 0.114 0.031 CID_681 | CID_681 | |
| 0.071 | 0.009 | 0.071 | Carbonic anhydrase I stimulant | 0.062 0.011 CID_681 | ||
| 0.069 | 0.008 | 0.069 | Sirtuin 2 inhibitor | 0.064 0.009 CID_681 | ||
| 0.074 | 0.012 | 0.074 | Carbonic anhydrase II stimulant | 0.071 0.013 CID_681 | ||
| 0.084 | 0.023 | 0.095 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.083 0.023 CID_193088 0.095 0.018 CID_681 | CID_681 | |
| 0.095 | 0.033 | 0.126 | Interferon agonist | 0.126 0.015 CID_193088 0.085 0.044 CID_681 | CID_193088 | |
| 0.079 | 0.018 | 0.082 | Botulinum neurotoxin type A inhibitor | 0.082 0.016 CID_681 | CID_681 | |
| 0.074 | 0.013 | 0.074 | Estrogen receptor alpha agonist | 0.029 0.027 CID_681 | ||
| 0.082 | 0.022 | 0.082 | Estrogen agonist | |||
| 0.07 | 0.01 | 0.07 | Oxytocin agonist | 0.065 0.013 CID_681 | ||
| 0.085 | 0.025 | 0.085 | NMDA receptor glycine site agonist | 0.078 0.03 CID_681 | ||
| 0.105 | 0.046 | 0.128 | Interleukin 12 antagonist | 0.128 0.023 CID_193088 0.085 0.083 CID_681 | CID_193088 | |
| 0.123 | 0.064 | 0.147 | Beta amyloid protein antagonist | 0.147 0.043 CID_193088 0.135 0.053 CID_681 | CID_193088 | |
| 0.077 | 0.018 | 0.077 | Opioid mu receptor agonist | 0.047 0.031 CID_681 | ||
| 0.073 | 0.014 | 0.073 | Ryanodine receptor antagonist | 0.072 0.015 CID_681 | ||
| 0.098 | 0.039 | 0.098 | Catalase inhibitor | 0.081 0.047 CID_681 | ||
| 0.078 | 0.02 | 0.078 | Opioid agonist | 0.053 0.037 CID_681 | ||
| 0.102 | 0.044 | 0.117 | Protein kinase A inhibitor | 0.117 0.035 CID_681 | CID_681 | |
| 0.087 | 0.03 | 0.088 | Dopamine D1 antagonist | 0.088 0.029 CID_681 | CID_681 | |
| 0.076 | 0.02 | 0.076 | Sphingosine 1-phosphate receptor 3 antagonist | 0.066 0.03 CID_681 | ||
| 0.072 | 0.015 | 0.072 | Estrogen receptor beta agonist | |||
| 0.064 | 0.009 | 0.064 | Somatostatin 5 agonist | 0.052 0.012 CID_681 | ||
| 0.064 | 0.009 | 0.064 | AMPA 4 receptor antagonist | 0.046 0.018 CID_681 | ||
| 0.077 | 0.022 | 0.077 | NMDA 2B receptor antagonist | |||
| 0.205 | 0.151 | 0.248 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.248 0.109 CID_681 | CID_681 | |
| 0.069 | 0.015 | 0.069 | Carbonic anhydrase IV inhibitor | 0.066 0.016 CID_681 | ||
| 0.061 | 0.008 | 0.061 | Histamine H1 receptor agonist | 0.057 0.01 CID_681 | ||
| 0.076 | 0.023 | 0.076 | Plasmin inhibitor | 0.066 0.026 CID_681 | ||
| 0.074 | 0.021 | 0.078 | Calcium channel P-type blocker | 0.078 0.017 CID_681 | CID_681 | |
| 0.061 | 0.008 | 0.061 | Glutamate (mGluR3) antagonist | 0.053 0.011 CID_681 | ||
| 0.089 | 0.037 | 0.089 | 5 Hydroxytryptamine 1F antagonist | 0.082 0.041 CID_681 | ||
| 0.095 | 0.043 | 0.095 | Acetylcholine nicotinic antagonist | 0.089 0.047 CID_681 | ||
| 0.098 | 0.046 | 0.098 | 5 Hydroxytryptamine 2C antagonist | 0.094 0.05 CID_681 | ||
| 0.062 | 0.01 | 0.069 | Alpha 1d adrenoreceptor agonist | 0.069 0.007 CID_681 | CID_681 | |
| 0.059 | 0.008 | 0.059 | 5 Hydroxytryptamine 1D agonist | 0.042 0.013 CID_681 | ||
| 0.095 | 0.044 | 0.095 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.085 0.055 CID_681 | ||
| 0.079 | 0.028 | 0.079 | Protease 3C (Human rhinovirus) inhibitor | 0.069 0.039 CID_681 | ||
| 0.092 | 0.041 | 0.142 | Glycine receptor antagonist | 0.142 0.009 CID_193088 0.081 0.055 CID_681 | CID_193088 | |
| 0.058 | 0.008 | 0.058 | Kainate receptor agonist | 0.054 0.01 CID_681 | ||
| 0.07 | 0.02 | 0.113 | Leukotriene B4 antagonist | 0.113 0.008 CID_193088 0.077 0.017 CID_681 | CID_193088 | |
| 0.109 | 0.059 | 0.336 | AMP-activated protein kinase stimulant | 0.336 0.004 CID_193088 0.118 0.051 CID_681 | CID_193088 | |
| 0.058 | 0.008 | 0.062 | Glutamate (mGluR8) agonist | 0.062 0.006 CID_681 | CID_681 | |
| 0.08 | 0.031 | 0.08 | 5 Hydroxytryptamine 1D antagonist | 0.06 0.049 CID_681 | ||
| 0.076 | 0.027 | 0.099 | Interferon inducer | 0.099 0.013 CID_193088 0.069 0.037 CID_681 | CID_193088 | |
| 0.15 | 0.101 | 0.272 | ATPase inhibitor | 0.272 0.009 CID_193088 0.162 0.081 CID_681 | CID_193088 | |
| 0.062 | 0.013 | 0.062 | AICAR transformylase inhibitor | 0.051 0.021 CID_681 | ||
| 0.1 | 0.051 | 0.1 | Toll-Like receptor 3 antagonist | 0.091 0.066 CID_681 | ||
| 0.117 | 0.069 | 0.26 | Topoisomerase II inhibitor | 0.26 0.023 CID_193088 0.113 0.073 CID_681 | CID_193088 | |
| 0.079 | 0.031 | 0.079 | Protein kinase C beta inhibitor | 0.079 0.032 CID_681 | ||
| 0.127 | 0.079 | 0.158 | Alkaline phosphatase inhibitor | 0.132 0.074 CID_193088 0.158 0.054 CID_681 | CID_681 | |
| 0.102 | 0.055 | 0.113 | Antiadrenergic | 0.113 0.048 CID_681 | CID_681 | |
| 0.074 | 0.027 | 0.074 | I kappa B kinase 2 inhibitor | 0.065 0.039 CID_681 | ||
| 0.12 | 0.073 | 0.219 | DNA repair enzyme inhibitor | 0.219 0.007 CID_193088 0.119 0.074 CID_681 | CID_193088 | |
| 0.057 | 0.011 | 0.064 | Sphingosine kinase 1 inhibitor | 0.064 0.008 CID_681 | CID_681 | |
| 0.06 | 0.015 | 0.06 | Somatostatin 1 antagonist | 0.045 0.023 CID_681 | ||
| 0.091 | 0.047 | 0.091 | I kappa B kinase inhibitor | 0.085 0.054 CID_681 | ||
| 0.137 | 0.093 | 0.137 | MAP kinase kinase 4 inhibitor | |||
| 0.076 | 0.032 | 0.076 | Exportin-1 inhibitor | 0.073 0.037 CID_681 | ||
| 0.062 | 0.019 | 0.062 | Adenosine deaminase inhibitor | 0.059 0.022 CID_193088 0.057 0.023 CID_681 | ||
| 0.065 | 0.023 | 0.065 | Histamine agonist | 0.06 0.028 CID_681 | ||
| 0.082 | 0.04 | 0.084 | Thrombin inhibitor | 0.084 0.038 CID_681 | CID_681 | |
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR4) antagonist | 0.048 0.023 CID_681 | ||
| 0.049 | 0.008 | 0.049 | Lysine carboxypeptidase inhibitor | 0.036 0.012 CID_681 | ||
| 0.044 | 0.003 | 0.044 | Estrogen-related receptor gamma agonist | 0.042 0.003 CID_681 | ||
| 0.063 | 0.022 | 0.063 | Bombesin 2 receptor antagonist | 0.057 0.026 CID_681 | ||
| 0.053 | 0.012 | 0.053 | Fumarate hydratase inhibitor | 0.04 0.019 CID_193088 0.046 0.015 CID_681 | ||
| 0.074 | 0.034 | 0.074 | Acetylcholine M2 receptor antagonist | |||
| 0.088 | 0.048 | 0.179 | Topoisomerase II alpha inhibitor | 0.179 0.018 CID_193088 0.08 0.053 CID_681 | CID_193088 | |
| 0.07 | 0.031 | 0.07 | Ribonucleotide reductase inhibitor | 0.065 0.034 CID_681 | ||
| 0.043 | 0.004 | 0.043 | Estrogen-related receptor gamma antagonist | 0.037 0.006 CID_681 | ||
| 0.043 | 0.004 | 0.047 | Beta 1 adrenoreceptor agonist | 0.047 0.004 CID_681 | CID_681 | |
| 0.054 | 0.016 | 0.054 | GABA B receptor antagonist | 0.046 0.025 CID_681 | ||
| 0.095 | 0.056 | 0.106 | Adrenaline antagonist | 0.106 0.05 CID_681 | CID_681 | |
| 0.158 | 0.119 | 0.158 | Anticonvulsant | |||
| 0.088 | 0.05 | 0.101 | Glutathione S-transferase inhibitor | 0.101 0.036 CID_681 | CID_681 | |
| 0.089 | 0.052 | 0.089 | Hematopoietic | |||
| 0.051 | 0.015 | 0.051 | GABA uptake inhibitor | 0.045 0.02 CID_681 | ||
| 0.097 | 0.061 | 0.097 | Interleukin 1 beta converting enzyme inhibitor | 0.086 0.079 CID_681 | ||
| 0.091 | 0.055 | 0.1 | Calcium antagonist | 0.1 0.048 CID_681 | CID_681 | |
| 0.058 | 0.022 | 0.071 | Squalene epoxidase inhibitor | 0.071 0.013 CID_681 | CID_681 | |
| 0.11 | 0.074 | 0.113 | Proteasome inhibitor | 0.113 0.072 CID_681 | CID_681 | |
| 0.11 | 0.075 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.065 | 0.031 | 0.065 | Ribonucleoside-diphosphate reductase inhibitor | 0.06 0.034 CID_681 | ||
| 0.043 | 0.009 | 0.043 | Estrogen-related receptor beta antagonist | |||
| 0.069 | 0.035 | 0.073 | Trypsin inhibitor | 0.073 0.031 CID_681 | CID_681 | |
| 0.038 | 0.004 | 0.062 | Vanilloid 2 agonist | 0.062 0.002 CID_193088 0.041 0.004 CID_681 | CID_193088 | |
| 0.201 | 0.167 | 0.276 | Caspase 3 stimulant | 0.276 0.093 CID_193088 0.235 0.126 CID_681 | CID_193088 | |
| 0.048 | 0.014 | 0.048 | Opioid delta receptor agonist | 0.035 0.025 CID_681 | ||
| 0.042 | 0.008 | 0.042 | Glutamate (mGluR3) agonist | 0.04 0.01 CID_681 | ||
| 0.08 | 0.047 | 0.08 | Protein kinase B gamma inhibitor | 0.072 0.055 CID_681 | ||
| 0.064 | 0.031 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.075 0.023 CID_193088 0.057 0.038 CID_681 | CID_193088 | |
| 0.039 | 0.005 | 0.064 | Dopamine D1 agonist | 0.04 0.005 CID_193088 0.064 0.004 CID_681 | CID_681 | |
| 0.058 | 0.024 | 0.058 | Neurotensin receptor antagonist | 0.042 0.034 CID_681 | ||
| 0.043 | 0.01 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.009 CID_681 | CID_681 | |
| 0.052 | 0.02 | 0.052 | Growth hormone release inhibitor | 0.042 0.029 CID_681 | ||
| 0.045 | 0.012 | 0.045 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.014 CID_681 | ||
| 0.053 | 0.02 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.071 0.007 CID_193088 0.053 0.02 CID_681 | CID_193088 | |
| 0.161 | 0.129 | 0.161 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.074 | 0.042 | 0.074 | Neuronal nicotinic receptor antagonist | 0.067 0.047 CID_681 | ||
| 0.056 | 0.024 | 0.056 | 5 Hydroxytryptamine 2C agonist | 0.046 0.031 CID_681 | ||
| 0.066 | 0.035 | 0.066 | Plasminogen activator inhibitor | 0.06 0.039 CID_681 | ||
| 0.051 | 0.02 | 0.051 | Glutamate (mGluR group III) antagonist | 0.043 0.032 CID_681 | ||
| 0.099 | 0.068 | 0.099 | Nav1.1 sodium channel blocker | |||
| 0.038 | 0.007 | 0.041 | Thyroid hormone agonist | 0.041 0.006 CID_681 | CID_681 | |
| 0.047 | 0.017 | 0.047 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.023 CID_681 | ||
| 0.151 | 0.121 | 0.151 | MAP kinase kinase 2 inhibitor | |||
| 0.147 | 0.117 | 0.163 | Pyruvate kinase inhibitor | 0.163 0.105 CID_681 | CID_681 | |
| 0.04 | 0.01 | 0.04 | Dopamine autoreceptor agonist | |||
| 0.064 | 0.034 | 0.064 | Dopamine uptake inhibitor | 0.055 0.043 CID_681 | ||
| 0.055 | 0.025 | 0.062 | Factor III inhibitor | 0.062 0.016 CID_193088 0.053 0.028 CID_681 | CID_193088 | |
| 0.064 | 0.035 | 0.076 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.076 0.022 CID_681 | CID_681 | |
| 0.124 | 0.094 | 0.157 | Mannose-6-phosphate isomerase inhibitor | 0.134 0.081 CID_193088 0.157 0.059 CID_681 | CID_681 | |
| 0.124 | 0.095 | 0.127 | Farnesoid X receptor antagonist | 0.127 0.089 CID_681 | CID_681 | |
| 0.047 | 0.018 | 0.059 | TRPM8 blocker | 0.059 0.012 CID_681 | CID_681 | |
| 0.062 | 0.033 | 0.062 | Carbonic anhydrase I inhibitor | 0.056 0.039 CID_193088 0.057 0.037 CID_681 | ||
| 0.096 | 0.068 | 0.1 | Glutamate (mGluR7) agonist | 0.1 0.059 CID_681 | CID_681 | |
| 0.055 | 0.027 | 0.055 | CD45 antagonist | 0.05 0.034 CID_681 | ||
| 0.053 | 0.025 | 0.08 | Glucose-6-phosphate isomerase inhibitor | 0.08 0.009 CID_193088 0.05 0.03 CID_681 | CID_193088 | |
| 0.069 | 0.041 | 0.069 | Carbonic anhydrase inhibitor | 0.065 0.043 CID_193088 0.062 0.044 CID_681 | ||
| 0.062 | 0.034 | 0.062 | Alpha 1 adrenoreceptor agonist | 0.062 0.034 CID_681 | ||
| 0.059 | 0.031 | 0.061 | Dihydroorotate oxidase inhibitor | 0.061 0.027 CID_681 | CID_681 | |
| 0.031 | 0.004 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 CID_193088 0.027 0.006 CID_681 | ||
| 0.061 | 0.034 | 0.061 | Carbonic anhydrase II inhibitor | 0.051 0.043 CID_193088 0.058 0.037 CID_681 | ||
| 0.048 | 0.021 | 0.048 | Sphingosine 1-phosphate receptor 1 agonist | 0.045 0.026 CID_681 | ||
| 0.036 | 0.009 | 0.036 | Purinergic P2Y15 antagonist | 0.035 0.01 CID_681 | ||
| 0.036 | 0.01 | 0.036 | 5 Hydroxytryptamine 6 agonist | 0.031 0.016 CID_681 | ||
| 0.063 | 0.038 | 0.063 | Acetylcholine M5 receptor antagonist | 0.057 0.046 CID_681 | ||
| 0.066 | 0.041 | 0.123 | Neuraminidase (influenza) inhibitor | 0.123 0.011 CID_193088 0.071 0.034 CID_681 | CID_193088 | |
| 0.042 | 0.017 | 0.042 | Somatostatin 5 antagonist | 0.038 0.019 CID_681 | ||
| 0.127 | 0.101 | 0.318 | Insulin secretagoues | 0.318 0.01 CID_193088 0.152 0.072 CID_681 | CID_193088 | |
| 0.134 | 0.109 | 0.147 | Protein kinase (CK1) gamma 3 inhibitor | 0.147 0.093 CID_681 | CID_681 | |
| 0.065 | 0.04 | 0.067 | Transcription factor RelA inhibitor | 0.067 0.035 CID_681 | CID_681 | |
| 0.062 | 0.037 | 0.062 | Neuropeptide agonist | |||
| 0.038 | 0.013 | 0.054 | Uridine phosphorylase inhibitor | 0.054 0.007 CID_193088 0.043 0.01 CID_681 | CID_193088 | |
| 0.039 | 0.014 | 0.039 | Endothelial nitric-oxide synthase inhibitor | 0.033 0.019 CID_681 | ||
| 0.068 | 0.044 | 0.068 | Potassium channel (ATP-sensitive) blocker | 0.065 0.051 CID_681 | ||
| 0.092 | 0.068 | 0.165 | Xanthine oxidase inhibitor | 0.165 0.029 CID_193088 0.101 0.059 CID_681 | CID_193088 | |
| 0.029 | 0.004 | 0.029 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 CID_681 | ||
| 0.058 | 0.034 | 0.113 | Carbonic anhydrase XII inhibitor | 0.113 0.018 CID_193088 0.051 0.038 CID_681 | CID_193088 | |
| 0.105 | 0.082 | 0.141 | Microtubule formation inhibitor | 0.141 0.042 CID_193088 0.113 0.069 CID_681 | CID_193088 | |
| 0.068 | 0.044 | 0.071 | MDM2 inhibitor | 0.071 0.037 CID_681 | CID_681 | |
| 0.05 | 0.027 | 0.05 | Complement C3a chemotactic receptor antagonist | 0.04 0.033 CID_681 | ||
| 0.044 | 0.021 | 0.044 | Vascular adhesion protein 1 inhibitor | 0.037 0.029 CID_681 | ||
| 0.045 | 0.023 | 0.045 | Plasmepsin II inhibitor | 0.043 0.025 CID_681 | ||
| 0.097 | 0.075 | 0.222 | Beta glucuronidase inhibitor | 0.222 0.01 CID_193088 0.102 0.067 CID_681 | CID_193088 | |
| 0.088 | 0.065 | 0.088 | Protein kinase C delta inhibitor | 0.082 0.074 CID_681 | ||
| 0.096 | 0.074 | 0.096 | 5 Hydroxytryptamine 2 antagonist | 0.089 0.081 CID_681 | ||
| 0.092 | 0.07 | 0.144 | 5-Lipoxygenase inhibitor | 0.144 0.04 CID_681 | CID_681 | |
| 0.029 | 0.007 | 0.029 | Imidazoline I1 receptor antagonist | 0.024 0.011 CID_681 | ||
| 0.05 | 0.029 | 0.05 | Melanocortin antagonist | 0.043 0.038 CID_681 | ||
| 0.036 | 0.016 | 0.036 | AMPA 3 receptor antagonist | 0.025 0.024 CID_681 | ||
| 0.097 | 0.077 | 0.097 | Factor V inhibitor | 0.096 0.078 CID_681 | ||
| 0.037 | 0.017 | 0.037 | Dipeptidyl peptidase II inhibitor | 0.033 0.021 CID_681 | ||
| 0.044 | 0.025 | 0.044 | Heme oxygenase inhibitor | 0.043 0.029 CID_681 | ||
| 0.044 | 0.025 | 0.044 | Kainate receptor antagonist | |||
| 0.029 | 0.01 | 0.029 | Prostaglandin F2 alpha agonist | 0.027 0.01 CID_681 | ||
| 0.049 | 0.031 | 0.063 | Cytokine production stimulant | 0.063 0.01 CID_193088 | CID_193088 | |
| 0.039 | 0.02 | 0.039 | Calcitonin receptor agonist | 0.03 0.027 CID_681 | ||
| 0.036 | 0.018 | 0.036 | Carboxypeptidase B inhibitor | 0.033 0.023 CID_681 | ||
| 0.051 | 0.033 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.033 CID_681 | ||
| 0.04 | 0.022 | 0.04 | Tryptase inhibitor | 0.037 0.026 CID_681 | ||
| 0.091 | 0.073 | 0.131 | Phosphodiesterase 6D inhibitor | 0.131 0.017 CID_193088 0.096 0.06 CID_681 | CID_193088 | |
| 0.031 | 0.013 | 0.031 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.017 CID_681 | ||
| 0.058 | 0.041 | 0.058 | Aminopeptidase microsomal inhibitor | 0.057 0.041 CID_681 | ||
| 0.058 | 0.041 | 0.058 | Cathepsin L inhibitor | 0.051 0.05 CID_681 | ||
| 0.051 | 0.034 | 0.051 | Sigma receptor antagonist | |||
| 0.047 | 0.03 | 0.047 | Purinergic P2X4 antagonist | |||
| 0.054 | 0.037 | 0.054 | Protein kinase C epsilon inhibitor | 0.051 0.04 CID_681 | ||
| 0.03 | 0.014 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.008 CID_193088 0.029 0.018 CID_681 | CID_193088 | |
| 0.035 | 0.019 | 0.035 | Somatostatin agonist | |||
| 0.043 | 0.027 | 0.043 | Toll-Like receptor 2 agonist | 0.042 0.028 CID_193088 0.041 0.029 CID_681 | ||
| 0.073 | 0.058 | 0.075 | Nicotinic alpha4beta2 receptor antagonist | 0.075 0.055 CID_681 | CID_681 | |
| 0.049 | 0.034 | 0.054 | Topoisomerase II beta inhibitor | 0.054 0.028 CID_681 | CID_681 | |
| 0.023 | 0.007 | 0.036 | Antibiotic Anthracycline-like | 0.036 0.003 CID_193088 0.021 0.01 CID_681 | CID_193088 | |
| 0.058 | 0.043 | 0.058 | Aromatase inhibitor | 0.05 0.048 CID_681 | ||
| 0.063 | 0.048 | 0.069 | Leukotriene antagonist | 0.058 0.053 CID_193088 0.069 0.041 CID_681 | CID_681 | |
| 0.056 | 0.041 | 0.056 | Leukotriene C antagonist | 0.056 0.04 CID_681 | ||
| 0.059 | 0.045 | 0.059 | Cyclin D1 inhibitor | |||
| 0.03 | 0.016 | 0.03 | Urotensin II agonist | |||
| 0.062 | 0.048 | 0.062 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.032 | 0.019 | 0.032 | AMPA 1 receptor antagonist | |||
| 0.035 | 0.021 | 0.035 | Melatonin receptor 1A agonist | 0.035 0.02 CID_681 | ||
| 0.056 | 0.042 | 0.056 | Pregnane X receptor antagonist | 0.055 0.046 CID_681 | ||
| 0.033 | 0.019 | 0.033 | Somatostatin 2 antagonist | |||
| 0.025 | 0.012 | 0.025 | Glutamate (mGluR1a) agonist | 0.02 0.019 CID_681 | ||
| 0.03 | 0.017 | 0.03 | Sigma 2 receptor antagonist | |||
| 0.044 | 0.031 | 0.044 | Sphingosine 1-phosphate receptor agonist | |||
| 0.058 | 0.046 | 0.106 | Neuraminidase inhibitor | 0.106 0.013 CID_193088 0.066 0.037 CID_681 | CID_193088 | |
| 0.043 | 0.03 | 0.043 | Opioid kappa receptor agonist | |||
| 0.036 | 0.024 | 0.036 | Kainate receptor 2 antagonist | 0.031 0.029 CID_681 | ||
| 0.053 | 0.041 | 0.053 | Thromboxane synthase inhibitor | 0.052 0.044 CID_681 | ||
| 0.066 | 0.055 | 0.073 | Amidase inhibitor | 0.073 0.045 CID_681 | CID_681 | |
| 0.029 | 0.018 | 0.029 | Melatonin antagonist | 0.029 0.019 CID_681 | ||
| 0.036 | 0.025 | 0.036 | Glutamate (mGluR8) antagonist | 0.034 0.03 CID_193088 0.035 0.027 CID_681 | ||
| 0.028 | 0.017 | 0.028 | Melanocortin 5 antagonist | 0.023 0.022 CID_681 | ||
| 0.033 | 0.022 | 0.034 | Melatonin 2 agonist | 0.034 0.022 CID_681 | CID_681 | |
| 0.053 | 0.042 | 0.053 | Glucosylceramidase inhibitor | |||
| 0.019 | 0.008 | 0.019 | NMDA receptor phencyclidine site antagonist | |||
| 0.061 | 0.05 | 0.061 | Neutrophil collagenase inhibitor | 0.06 0.05 CID_681 | ||
| 0.068 | 0.057 | 0.078 | Histone deacetylase SIRT2 inhibitor | 0.078 0.047 CID_681 | CID_681 | |
| 0.036 | 0.026 | 0.09 | Antibiotic Aminoglycoside-like | 0.09 0.004 CID_193088 0.034 0.029 CID_681 | CID_193088 | |
| 0.032 | 0.022 | 0.032 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.02 | 0.009 | 0.025 | Alpha 2a adrenoreceptor agonist | 0.025 0.006 CID_681 | CID_681 | |
| 0.039 | 0.029 | 0.039 | Erythropoietin receptor agonist | |||
| 0.028 | 0.018 | 0.028 | Hedgehog signaling activator | 0.027 0.02 CID_681 | ||
| 0.068 | 0.058 | 0.068 | Phospholipase D inhibitor | |||
| 0.069 | 0.06 | 0.069 | Adenosine A3 receptor antagonist | |||
| 0.034 | 0.025 | 0.034 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.024 | 0.016 | 0.024 | Somatostatin 4 antagonist | |||
| 0.023 | 0.014 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CID_193088 0.024 0.013 CID_681 | CID_681 | |
| 0.026 | 0.018 | 0.026 | Acid ceramidase inhibitor | |||
| 0.025 | 0.018 | 0.025 | Complement factor 1s inhibitor | |||
| 0.124 | 0.117 | 0.124 | Pregnane X receptor agonist | |||
| 0.042 | 0.035 | 0.042 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.073 | 0.065 | 0.073 | Chymotrypsin inhibitor | |||
| 0.04 | 0.033 | 0.053 | Guanylate cyclase inhibitor | 0.053 0.018 CID_193088 | CID_193088 | |
| 0.031 | 0.024 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.236 | 0.23 | 0.55 | Apoptosis agonist | 0.55 0.06 CID_193088 0.329 0.153 CID_681 | CID_193088 | |
| 0.108 | 0.102 | 0.118 | Cytokine production inhibitor | 0.118 0.092 CID_681 | CID_681 | |
| 0.027 | 0.021 | 0.027 | Thrombin receptor antagonist | |||
| 0.026 | 0.02 | 0.026 | Nicotinic acid receptor 2 antagonist | |||
| 0.034 | 0.028 | 0.034 | Nicotinic acid receptor agonist | |||
| 0.016 | 0.011 | 0.016 | Adenosine A2 receptor agonist | 0.015 0.014 CID_681 | ||
| 0.05 | 0.045 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.015 | 0.01 | 0.015 | Adenosine A2a receptor agonist | |||
| 0.037 | 0.032 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.022 | 0.018 | 0.022 | Growth hormone releasing factor antagonist | |||
| 0.03 | 0.026 | 0.03 | ATP citrate lysase inhibitor | 0.03 0.025 CID_681 | ||
| 0.017 | 0.013 | 0.024 | Telomerase stimulant | 0.024 0.005 CID_193088 0.016 0.015 CID_681 | CID_193088 | |
| 0.067 | 0.063 | 0.067 | Metalloproteinase-9 inhibitor | 0.067 0.062 CID_681 | ||
| 0.012 | 0.008 | 0.016 | Glutamate (mGluR6) agonist | 0.016 0.005 CID_681 | CID_681 | |
| 0.023 | 0.02 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.057 | 0.054 | 0.073 | Purinergic P2X2 antagonist | 0.073 0.044 CID_681 | CID_681 | |
| 0.037 | 0.034 | 0.038 | Estradiol 17 beta-dehydrogenase inhibitor | 0.038 0.033 CID_681 | CID_681 | |
| 0.013 | 0.009 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 CID_681 | CID_681 | |
| 0.041 | 0.037 | 0.043 | Dihydrofolate reductase inhibitor | 0.043 0.03 CID_681 | CID_681 | |
| 0.07 | 0.067 | 0.07 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.017 | 0.013 | 0.017 | Aminopeptidase A inhibitor | |||
| 0.032 | 0.028 | 0.032 | Retinoid X alpha receptor agonist | |||
| 0.033 | 0.03 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.03 CID_193088 | ||
| 0.148 | 0.145 | 0.198 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.198 0.101 CID_681 | CID_681 | |
| 0.119 | 0.116 | 0.299 | NOS3 expression enhancer | 0.299 0.018 CID_193088 0.137 0.087 CID_681 | CID_193088 | |
| 0.011 | 0.008 | 0.011 | Beta 3 adrenoreceptor agonist | 0.01 0.009 CID_681 | ||
| 0.052 | 0.049 | 0.052 | Kallikrein 1 inhibitor | |||
| 0.023 | 0.021 | 0.023 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.033 | 0.031 | 0.033 | Melanocortin 1 antagonist | |||
| 0.096 | 0.094 | 0.096 | Nav1.5 sodium channel blocker | 0.096 0.093 CID_681 | ||
| 0.026 | 0.024 | 0.026 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.075 | 0.073 | 0.075 | Antineoplastic alkaloid | |||
| 0.024 | 0.023 | 0.104 | Sodium/glucose cotransporter 2 inhibitor | 0.104 0.003 CID_193088 | CID_193088 | |
| 0.019 | 0.018 | 0.02 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.018 CID_681 | CID_681 | |
| 0.045 | 0.045 | 0.048 | Prolyl endopeptidase inhibitor | 0.048 0.04 CID_681 | CID_681 | |
| 0.022 | 0.021 | 0.027 | Prostaglandin H2 antagonist | 0.027 0.016 CID_681 | CID_681 | |
| 0.008 | 0.008 | 0.009 | Thyroid hormone beta agonist | 0.009 0.006 CID_681 | CID_681 | |
| 0.024 | 0.024 | 0.093 | Sodium/glucose cotransporter inhibitor | 0.093 0.003 CID_193088 | CID_193088 | |
| 0.086 | 0.086 | 0.194 | Mediator release inhibitor | 0.194 0.016 CID_193088 0.088 0.084 CID_681 | CID_193088 | |
| 0.051 | 0.054 | 0.071 | Adenine nucleotide translocase inhibitor | 0.071 0.014 CID_193088 0.058 0.031 CID_681 | CID_193088 | |
| 0.028 | 0.031 | 0.073 | Catechol O-methyltransferase inhibitor | 0.073 0.005 CID_681 | CID_681 | |
| 0.044 | 0.047 | 0.065 | Carbonic anhydrase IX inhibitor | 0.065 0.035 CID_193088 | CID_193088 | |
| 0.019 | 0.025 | 0.071 | Protein 30S ribosomal subunit inhibitor | 0.071 0.005 CID_193088 | CID_193088 | |
| 0.026 | 0.035 | 0.029 | Melatonin agonist | 0.029 0.028 CID_681 | CID_681 | |
| 0.017 | 0.026 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.016 CID_193088 | CID_193088 | |
| 0.03 | 0.039 | 0.034 | Factor VIIa inhibitor | 0.034 0.032 CID_681 | CID_681 | |
| 0.046 | 0.056 | 0.157 | Heparanase inhibitor | 0.157 0.003 CID_193088 | CID_193088 | |
| 0.031 | 0.042 | 0.038 | Dopamine D5 antagonist | 0.038 0.034 CID_681 | CID_681 | |
| 0.042 | 0.054 | 0.072 | Alpha tubulin antagonist | 0.072 0.023 CID_681 | CID_681 | |
| 0.011 | 0.023 | 0.032 | Ileal bile acid transport inhibitor | 0.032 0.005 CID_193088 | CID_193088 | |
| 0.049 | 0.063 | 0.114 | HIV-1 integrase (3'-Processing) inhibitor | 0.114 0.021 CID_681 | CID_681 | |
| 0.048 | 0.063 | 0.395 | Selectin antagonist | 0.395 0.003 CID_193088 0.062 0.048 CID_681 | CID_193088 | |
| 0.11 | 0.127 | 0.135 | Protein-tyrosine phosphatase inhibitor | 0.135 0.095 CID_193088 0.135 0.095 CID_681 | CID_681 | |
| 0.007 | 0.024 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.007 CID_193088 | CID_193088 | |
| 0.082 | 0.113 | 0.094 | Folate antagonist | 0.094 0.076 CID_193088 | CID_193088 | |
| 0.054 | 0.089 | 0.088 | HIV-1 integrase inhibitor | 0.088 0.033 CID_681 | CID_681 | |
| 0.082 | 0.117 | 0.116 | Multidrug resistance-associated protein 1 inhibitor | 0.116 0.053 CID_193088 | CID_193088 | |
| 0.071 | 0.109 | 0.122 | Thioredoxin inhibitor | 0.122 0.029 CID_193088 | CID_193088 | |
| 0.035 | 0.076 | 0.061 | Prostaglandin EP2 antagonist | 0.061 0.04 CID_193088 | CID_193088 | |
| 0.047 | 0.089 | 0.069 | Lipocortins synthesis agonist | 0.069 0.023 CID_193088 | CID_193088 | |
| 0.037 | 0.08 | 0.096 | Glucose-6-phosphate translocase inhibitor | 0.096 0.007 CID_193088 0.054 0.032 CID_681 | CID_193088 | |
| 0.035 | 0.079 | 0.084 | HIV-1 integrase (Strand Transfer) inhibitor | 0.084 0.029 CID_681 | CID_681 | |
| 0.035 | 0.081 | 0.11 | Factor IXa inhibitor | 0.11 0.008 CID_193088 | CID_193088 | |
| 0.11 | 0.158 | 0.419 | Platelet adhesion inhibitor | 0.419 0.01 CID_193088 0.144 0.113 CID_681 | CID_193088 | |
| 0.024 | 0.074 | 0.087 | Phosphorylase inhibitor | 0.087 0.015 CID_193088 | CID_193088 | |
| 0.11 | 0.16 | 0.14 | Dual specificity phosphatase inhibitor | 0.14 0.107 CID_681 | CID_681 | |
| 0.066 | 0.117 | 0.158 | Transcription factor NF kappa B stimulant | 0.158 0.014 CID_193088 | CID_193088 | |
| 0.129 | 0.189 | 0.438 | Tumour necrosis factor alpha release inhibitor | 0.438 0.021 CID_193088 0.21 0.101 CID_681 | CID_193088 | |
| 0.019 | 0.081 | 0.049 | Factor Xa inhibitor | 0.049 0.03 CID_193088 | CID_193088 | |
| 0.173 | 0.241 | 0.41 | Alpha-glucosidase inhibitor | 0.41 0.11 CID_193088 | CID_193088 | |
| 0.08 | 0.148 | 0.122 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.122 0.1 CID_681 | CID_681 | |
| 0.057 | 0.129 | 0.109 | Falcipain inhibitor | 0.109 0.049 CID_193088 | CID_193088 | |
| 0.023 | 0.096 | 0.065 | Beta tubulin antagonist | 0.065 0.037 CID_681 | CID_681 | |
| 0.061 | 0.134 | 0.112 | Protein-tyrosine phosphatase 1B inhibitor | 0.112 0.069 CID_193088 | CID_193088 | |
| 0.055 | 0.13 | 0.106 | Falcipain 2 inhibitor | 0.106 0.049 CID_193088 | CID_193088 | |
| 0.046 | 0.127 | 0.07 | CDC25A inhibitor | 0.07 0.057 CID_681 | CID_681 | |
| 0.008 | 0.094 | 0.043 | Squalene synthetase inhibitor | 0.043 0.017 CID_193088 | CID_193088 | |
| 0.092 | 0.178 | 0.127 | Dual specificity phosphatase 3 inhibitor | 0.127 0.12 CID_681 | CID_681 | |
| 0.021 | 0.107 | 0.057 | Aldose reductase inhibitor | 0.057 0.034 CID_193088 | CID_193088 | |
| 0.06 | 0.147 | 0.141 | DNA intercalator | 0.141 0.047 CID_193088 | CID_193088 | |
| 0.073 | 0.167 | 0.102 | Electron transport complex I inhibitor | 0.102 0.079 CID_681 | CID_681 | |
| 0.055 | 0.15 | 0.116 | Uric acid excretion stimulant | 0.116 0.04 CID_193088 | CID_193088 | |
| 0.03 | 0.126 | 0.198 | Antineoplastic antibiotic | 0.198 0.021 CID_193088 | CID_193088 | |
| 0.192 | 0.288 | 0.781 | Cyclophilin D inhibitor | 0.781 0.008 CID_193088 0.246 0.217 CID_681 | CID_193088 | |
| 0.065 | 0.164 | 0.098 | T cell inhibitor | 0.098 0.026 CID_193088 | CID_193088 | |
| 0.1 | 0.205 | 0.147 | P-glycoprotein inhibitor | 0.147 0.122 CID_193088 | CID_193088 | |
| 0.091 | 0.215 | 0.182 | Antimitotic | 0.182 0.095 CID_681 | CID_681 | |
| 0.002 | 0.134 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_193088 | CID_193088 | |
| 0.02 | 0.163 | 0.111 | Protein 50S ribosomal subunit inhibitor | 0.111 0.011 CID_193088 | CID_193088 | |
| 0.103 | 0.25 | 0.145 | CC chemokine 6 receptor antagonist | 0.145 0.029 CID_193088 | CID_193088 | |
| 0.024 | 0.175 | 0.072 | Nitric oxide donor | 0.072 0.03 CID_193088 | CID_193088 | |
| 0.044 | 0.202 | 0.123 | ATPase (Vacuolar H+) inhibitor | 0.123 0.018 CID_193088 0.084 0.07 CID_681 | CID_193088 | |
| 0.126 | 0.288 | 0.492 | Immunomodulator | 0.492 0.024 CID_193088 | CID_193088 | |
| 0.008 | 0.183 | 0.026 | Motilin receptor agonist | 0.026 0.013 CID_193088 | CID_193088 | |
| 0.058 | 0.254 | 0.295 | Cell adhesion inhibitor | 0.295 0.01 CID_193088 | CID_193088 | |
| 0.017 | 0.222 | 0.044 | Microtubule stabilization | 0.044 0.035 CID_193088 | CID_193088 | |
| 0.039 | 0.252 | 0.11 | Tubulin antagonist | 0.11 0.091 CID_681 | CID_681 | |
| 0.028 | 0.245 | 0.075 | Histone deacetylase stimulant | 0.075 0.049 CID_193088 | CID_193088 | |
| 0.028 | 0.245 | 0.075 | Histone deacetylase SIRT1 stimulant | 0.075 0.049 CID_193088 | CID_193088 | |
| 0.062 | 0.308 | 0.279 | Hypolipemic | 0.279 0.056 CID_193088 | CID_193088 | |
| 0.034 | 0.303 | 0.147 | Cell adhesion molecule inhibitor | 0.147 0.016 CID_193088 | CID_193088 | |
| 0.012 | 0.377 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_193088 | CID_193088 | |
| 0.112 | 0.496 | 0.729 | Antiinflammatory | 0.729 0.026 CID_193088 | CID_193088 | |
| 0.07 | 0.455 | 0.235 | Antiobesity | 0.235 0.171 CID_193088 | CID_193088 | |
| 0.04 | 0.551 | 0.207 | Angiogenesis inhibitor | 0.207 0.161 CID_193088 | CID_193088 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |